PolistenaB., SpandonaroF., CapraR., FantacciniS., SantoniL., ZimatoreG., and GasperiniC. “The Societal Impact of Treatment With Natalizumab of Relapsing–remitting Multiple Sclerosis in Italian Clinical Practice: The Tysabri® PharmacoEconomics (TyPE) Study”. Global & Regional Health Technology Assessment, Vol. 6, no. 1, June 2019, doi:10.33393/grhta.2019.463.